Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Broyhill Asset Management. This analysis is provided for institutional research purposes only and is not investment advice.
"Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record market dispersion as a historic setup for fundamental stock picking."
In their Q2 2025 investor letter, Broyhill Asset Management reports a net return of 3.7% for the quarter and 6.6% for the first half of 2025, lagging behind the MSCI ACWI's 11.7% Q2 rally. Top contributors for the quarter were Philip Morris (PM) and Dollar Tree (DLTR), while Avantor (AVTR) and Fiserv (FI) detracted. Broyhill took advantage of market dislocations—including those stemming from 'Liberation Day' and tariff worries—to aggressively add to key holdings like Fiserv and Dollar Tree, and initiate a new position in IQVIA (IQV). They also consolidated their offshore energy exposure into Noble Corporation (NE) while exiting Schwab, Tidewater, and Valaris. The letter strongly critiques the concentration of the S&P 500 (where the top 10 stocks make up 38% of the index) and outlines the firm's pivot toward under-owned, smaller-cap global and international companies. They express high confidence in their healthcare holdings and expect mean reversion and multiple near-term catalysts to drive outsized gains.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Growth Outlook
Market outlook remains above average conviction: Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Risk Appetite
Risk appetite posture is above average conviction: Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Forward Guidance
Forward guidance signal: Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Language Signal
Tone analysis indicates high conviction language: Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
Time Horizon
Investment time horizon reflects a high conviction orientation. Broyhill returned 3.7% in Q2 2025, underperforming the global rally but actively repositioning into high-conviction, smaller-cap, and healthcare targets. The manager sees record ma...
